Limits the recovery for personal injuries actions against any town to $3,000 retroactive to all causes of action arising after January 1, 2025, and prohibits the use of subsequent remedial measures in roadway/highway defect cases.
Maddy summaryHB 5931 repeals a law that allowed motor vehicle license suspension for failure to pay traffic fines. This bill directly affects drivers who cannot pay court-imposed fines for traffic violations. The key provision removes the requirement that license suspensions remain in effect until all fines are paid or payment arrangements are made with the court. The repeal eliminates this enforcement mechanism for unpaid traffic fines.
Exempts recovery claims for damages due to a town's neglect in maintaining highways or bridges from the provisions of chapter 31 of title 9 on governmental tort liability.
Caps damages at $100,000 in tort actions against Rhode Island, cities, towns, or fire districts, except for willful misconduct or extreme recklessness. It also exempts them from § 9-21-10.
Maddy summaryHB 5860 would prohibit Rhode Island state entities, health insurance plans, and participating ERISA plans from purchasing prescription drugs above a federally set "maximum fair price" (based on U.S. Department of Health and Human Services rates). The law requires these entities to use any savings from this price cap to directly reduce costs for consumers, with a focus on addressing health equity disparities. Annual reports detailing savings and how they were used to lower consumer costs must be submitted to the state insurance commissioner. This bill affects all state-funded health programs, private health insurers, and employer-sponsored health plans that choose to participate.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Requires the secretary of the executive office of health and human services to monitor and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model.
Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.
Requires DCYF to implement recommendations made by the child advocate and child fatality review panel within 6 months and provide a report of the measures taken to address the recommendations.
